Ep78: The Future of ADHD Treatment: Using a Digital Device to Re-Focus Attention

In this episode, we hear from, Rich Brancaccio, Chief Innovation Officer of Revibe Technologies, and Lindsay Ayearst, Chief Scientific Officer of Revibe Technologies.

In their own words, Revibe is a digital therapeutics company fusing behavioral science with technology and currently developing a new digital therapy for ADHD.

In this episode, we cover:

• Founding story and funding milestones
• Child and caregiver experience using Revibe
• Quantifying attention & capturing focus data
• Evidence generation journey & clinical endpoints
• The ADHD market choice to focus on adolescent ADHD
• Lessons learned from the first wave of similar products and companies
• OTC vs PDT

Guest Links and Resources:

• Connect with Lindsay Ayearst on LinkedIn
• Connect with Rich Brancaccio on LinkedIn
• Visit www.revibetech.com

Host Links:

• Connect with Eugene Borukhovich: Twitter | LinkedIn
• Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn
• Connect with YourCoach.health: Website | Twitter
• Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App
• HealthXL: Website | Twitter | Join an Event

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram